Recognises human DNGR-1, also known as CLEC9A, which is a highly specific marker of a human DC subset, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.
| Institute |
|---|
| Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151707 |
|---|---|
| Product description: | Recognises human DNGR-1, also known as CLEC9A, which is a highly specific marker of a human DC subset, as well as a receptor able to recognise a preformed signal exposed on necrotic cells. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Immunogen: | RBL-2H3 cells expressing human DNGR-1 fused to an HA epitope |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 151707 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Immunology; Stem cell biology |
| Application: | FACS ; IHC ; FACS ; IF |
| Target: | Human DNGR1 |
| Reactivity: | Human |
| Clone: | 8F9 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Recognises human DNGR-1, also known as CLEC9A, which is a highly specific marker of a human DC subset, as well as a receptor able to recognise a preformed signal exposed on necrotic cells. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Poulin et al. 2010. J Exp Med. 207:1261-71. [PMID: 20479117] Sancho et al. 2008. J Clin Invest 118:2098-110 .[PMID: 18497879] Sancho et al. 2009. Nature. 458:899-903. [PMID: 19219027] Canavan et al. 2018. JCI Insight. 3(23):. PMID: 30518680. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.